Intellia Therapeutics, Inc. (NTLA) Social Stream
INTELLIA THERAPEUTICS INC (NTLA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NTLA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-07 | 16 | $193 | $85 | $157.133 | $29.78 | 427.65% |
| 2022-01-28 | 16 | $193 | $85 | $156.5 | $29.78 | 425.52% |
| 2022-02-03 | 17 | $193 | $85 | $156.5 | $29.78 | 425.52% |
| 2022-02-04 | 17 | $193 | $85 | $151.437 | $29.78 | 408.52% |
| 2022-02-07 | 18 | $193 | $85 | $151.75 | $29.78 | 409.57% |
| 2022-02-25 | 19 | $193 | $85 | $151.75 | $29.78 | 409.57% |
| 2022-02-28 | 17 | $193 | $85 | $151.75 | $29.78 | 409.57% |
| 2022-03-01 | 17 | $193 | $85 | $152.375 | $29.78 | 411.67% |
| 2022-03-03 | 17 | $193 | $85 | $152.062 | $29.78 | 410.62% |
| 2022-03-07 | 18 | $193 | $85 | $148.47 | $29.78 | 398.56% |
| 2022-04-25 | 17 | $193 | $85 | $146.375 | $29.78 | 391.52% |
| 2022-05-05 | 16 | $193 | $85 | $148.8 | $29.78 | 399.66% |
| 2022-05-06 | 16 | $193 | $55 | $140.2 | $29.78 | 370.79% |
| 2022-05-09 | 16 | $193 | $55 | $138.2 | $29.78 | 364.07% |
| 2022-05-24 | 17 | $193 | $55 | $137.375 | $29.78 | 361.3% |
| 2022-06-16 | 19 | $193 | $55 | $133.411 | $29.78 | 347.99% |
| 2022-06-17 | 19 | $193 | $54 | $129 | $29.78 | 333.18% |
| 2022-07-17 | 18 | $193 | $54 | $131.437 | $29.78 | 341.36% |
| 2022-08-03 | 18 | $193 | $54 | $132.312 | $29.78 | 344.3% |
| 2022-08-05 | 18 | $193 | $54 | $132.625 | $29.78 | 345.35% |
| 2022-08-15 | 18 | $192 | $54 | $130.125 | $29.78 | 336.95% |
| 2022-09-01 | 19 | $192 | $50 | $125.411 | $29.78 | 321.12% |
| 2022-09-16 | 19 | $192 | $50 | $124.588 | $29.78 | 318.36% |
| 2022-09-19 | 19 | $192 | $50 | $125.823 | $29.78 | 322.51% |
| 2022-09-23 | 20 | $192 | $50 | $125.111 | $29.78 | 320.12% |
| 2022-10-23 | 20 | $192 | $50 | $120.333 | $29.78 | 304.07% |
| 2022-10-24 | 20 | $192 | $50 | $116.555 | $29.78 | 291.39% |
| 2022-11-01 | 21 | $192 | $50 | $117.263 | $29.78 | 293.76% |
| 2022-11-04 | 21 | $192 | $50 | $116.789 | $29.78 | 292.17% |
| 2022-11-06 | 21 | $192 | $50 | $112.157 | $29.78 | 276.62% |
| 2022-11-14 | 21 | $180 | $50 | $110.842 | $29.78 | 272.2% |
| 2022-11-15 | 21 | $180 | $50 | $111.263 | $29.78 | 273.62% |
| 2022-12-01 | 21 | $180 | $50 | $111.105 | $29.78 | 273.09% |
| 2022-12-02 | 21 | $180 | $50 | $110.894 | $29.78 | 272.38% |
| 2023-01-02 | 21 | $180 | $50 | $110.947 | $29.78 | 272.56% |
| 2023-01-04 | 22 | $180 | $50 | $111.4 | $29.78 | 274.08% |
| 2023-01-05 | 22 | $180 | $50 | $109.3 | $29.78 | 267.02% |
| 2023-01-11 | 21 | $180 | $48 | $108.789 | $29.78 | 265.31% |
| 2023-01-23 | 21 | $180 | $48 | $108.684 | $29.78 | 264.96% |
| 2023-01-26 | 21 | $180 | $39 | $108.105 | $29.78 | 263.01% |
| 2023-02-08 | 21 | $180 | $39 | $106.05 | $29.78 | 256.11% |
| 2023-02-24 | 23 | $180 | $39 | $102.3 | $29.78 | 243.52% |
| 2023-03-02 | 23 | $180 | $39 | $96.095 | $29.78 | 222.68% |
| 2023-03-14 | 23 | $180 | $39 | $96.238 | $29.78 | 223.16% |
| 2023-03-21 | 24 | $180 | $39 | $94.318 | $29.78 | 216.72% |
| 2023-03-31 | 24 | $180 | $39 | $94.181 | $29.78 | 216.26% |
| 2023-04-13 | 25 | $180 | $39 | $92.956 | $29.78 | 212.14% |
| 2023-05-05 | 25 | $180 | $39 | $92.478 | $29.78 | 210.54% |
| 2023-05-08 | 25 | $180 | $39 | $91.695 | $29.78 | 207.91% |
| 2023-06-12 | 23 | $144 | $42 | $84.761 | $29.78 | 184.62% |
| 2023-07-17 | 23 | $144 | $42 | $84.666 | $29.78 | 184.3% |
| 2023-08-04 | 24 | $144 | $42 | $84.38 | $29.78 | 183.34% |
| 2023-08-07 | 24 | $144 | $40 | $84.409 | $29.78 | 183.44% |
| 2023-10-03 | 24 | $144 | $40 | $84.181 | $29.78 | 182.68% |
| 2023-10-18 | 23 | $144 | $40 | $82.523 | $29.78 | 177.11% |
| 2023-11-02 | 23 | $144 | $40 | $82.19 | $29.78 | 175.99% |
| 2023-11-09 | 23 | $144 | $29 | $80.714 | $29.78 | 171.03% |
| 2023-11-13 | 24 | $145 | $29 | $77.523 | $29.78 | 160.32% |
The Trend in the Analyst Price Target
NTLA's average price target has moved down $27.6 over the prior 40 weeks.
NTLA reports an average of 148% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 21 | 180 | 39 | 106.050 | 43.11 | 146% |
| 2023-03-31 | 24 | 180 | 39 | 94.181 | 37.27 | 152.7% |
| 2023-08-04 | 23 | 144 | 42 | 84.380 | 39.61 | 113.03% |
| 2023-08-07 | 24 | 144 | 40 | 84.409 | 39.02 | 116.32% |
| 2023-11-13 | 24 | 145 | 29 | 78.454 | 23.81 | 229.5% |
NTLA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 19 | 1 | 4 | 0 | 0 | 24 |
The Trend in the Broker Recommendations
Over the past 35 weeks, NTLA's average broker recommendation rating worsened by 0.09.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- NTLA has a greater number of analysts covering the stock than 7255.79% of all US stocks.
- In terms of how INTELLIA THERAPEUTICS INC fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 7587.41% of that group.
- INTELLIA THERAPEUTICS INC's variance in analysts' estimates is lower than -7065.84% of stocks in the large market cap category.
- In terms of how INTELLIA THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 6841.42% of that group.
Stocks similar to INTELLIA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IDXX, QDEL, and TAK.
View All Top Stocks by Price Target
What is the outlook for NTLA? Use POWR Ratings for clearer insight into price direction.